Nonmyeloablative Stem Cell Transplantation Is an Effective Therapy for Refractory or Relapsed Hodgkin Lymphoma: Results of a Spanish Prospective Cooperative ProtocolIván Alvarez, Jorge Sierra, Álvaro Urbano-Ispizúa et al.|Transplantation and Cellular Therapy|2006Cited by 142
Reduced‐intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long‐term outcomesKarl S. Peggs, Anna Sureda, Wendi Qian et al.|British Journal of Haematology|2007Cited by 106